Tarsons Products Share Price Today | Stock Price & Tarsons Products Share Screener
As of October 5, 2026, the live Tarsons Products share price (NSE: TARSONS) is ₹335.95 on NSE and ₹335.65 on BSE, up 1.99% from the previous close, with shares trading between ₹327.05 and ₹343.45 in today's trading session, and a 52-week range of ₹166.46–₹361.50. Check Tarsons Products yearly highs lows for the annual price range and momentum. Use the Tarsons Products stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Tarsons Products opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹116 and net income of ₹-1, with EBITDA of ₹32, an operating margin of 24.0% and a profit margin of -0.9%.
Tarsons Products Share Price Chart
Track the current stock price of Tarsons Products with an interactive chart. Analyse TARSONS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Tarsons Products stock quote in one place.
The quote of ₹335.95 sits between the 52-week low of ₹166.46 and the 52-week high of ₹361.50, and the latest session moved 1.99% from the previous close.
Tarsons Products Company Profile - Fundamental Screener
Screen Tarsons Products company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TARSONS shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Medical Equipment industry, and it trades under ISIN INE144Z01023.
Company Details
Classification
Identifiers and Leadership
Tarsons Products Balance Sheet Screener
Screen TARSONS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹1,186, up from ₹1,080 in 2025.
Latest statistics put total assets at ₹1,186 and shareholder funds at ₹635, with a leverage ratio of 0.58.
| Item | 2026 | 2025 | 2024 | 2022 | 2021 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 1,186 | 1,080 | 972 | 544 | 296 |
| Current Assets | 266 | 243 | 235 | 245 | 113 |
| Fixed Assets | 733 | 536 | 336 | 189 | 120 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 287 | 274 | 146 | 20 | 10 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 635 | 630 | 613 | 490 | 244 |
| Share Capital | 11 | 11 | 11 | 11 | 0 |
| Reserves & Surplus | 624 | 620 | 602 | 479 | 244 |
Tarsons Products Income Statement Screener - Profit & Revenue Analysis
Screen Tarsons Products income statement and profit fundamentals. Analyze TARSONS quarterly results. Tarsons Products reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹116 and net profit was ₹-1, equal to earnings per unit of ₹-0.27, at an operating margin of 24%.
In that period expenses were ₹84, interest cost ₹6 and tax ₹0. The next period listed, 2026-Mar, shows revenue of ₹128 and net profit of ₹4.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2022-Mar | 2021-Dec | 2021-Sept | 2021-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 116 | 128 | 116 | 108 | 95 | 117 | 97 | 108 | 88 | 109 | 65 | 88 | 73 | 77 | 71 |
| Expenses | 84 | 87 | 78 | 75 | 67 | 76 | 66 | 74 | 66 | 76 | 39 | 41 | 38 | 38 | 32 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 32 | 41 | 39 | 33 | 28 | 41 | 31 | 34 | 22 | 34 | 26 | 47 | 36 | 40 | 39 |
| Operating Profit % | 24.00% | 28.00% | 28.00% | 27.00% | 27.00% | 33.00% | 31.00% | 26.00% | 22.00% | 29.00% | 37.00% | 52.00% | 47.00% | 50.00% | 53.00% |
| Depreciation | 27 | 29 | 25 | 23 | 20 | 20 | 17 | 14 | 11 | 12 | 10 | 7 | 5 | 5 | 5 |
| Interest | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 0 | 1 | 2 | 1 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -1 | 6 | 8 | 6 | 3 | 16 | 8 | 15 | 6 | 17 | 14 | 39 | 29 | 34 | 33 |
| Tax | 0 | 2 | 3 | 2 | 1 | 5 | 3 | 5 | 2 | 7 | 4 | 10 | 7 | 9 | 9 |
| Net Profit | -1 | 4 | 5 | 3 | 2 | 10 | 5 | 10 | 4 | 10 | 10 | 30 | 22 | 25 | 25 |
| EPS | -0.27 | 0.79 | 0.95 | 0.62 | 0.34 | 1.92 | 0.99 | 1.93 | 0.75 | 1.94 | 1.87 | 5.69 | 4.14 | 4.89 | 4.88 |
Tarsons Products Cash Flow Screener - Liquidity Fundamentals
Screen TARSONS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹119, and net cash flow was an outflow of ₹2.
Over the same period, investing activities used ₹129 and financing activities provided ₹9.
| Item | 2026-March | 2025-March | 2024-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
Cash from Operations and Investing | |||||
| Operating Activities | 119 | 114 | 103 | 84 | 68 |
| Investing Activities | -129 | -145 | -285 | -138 | -64 |
Financing and Net Cash | |||||
| Financing Activities | 9 | 39 | 136 | 130 | -27 |
| Net Cash Flow | -2 | 8 | -47 | 75 | -23 |
Tarsons Products Shareholding Pattern Screener
See Tarsons Products shareholding pattern with promoter, FII, and DII holdings. Check Tarsons Products promoter holding and ownership changes for TARSONS on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 47.30%, foreign institutions 0.16%, domestic institutions 0.10% and the public 22.58%, spread across 83,453 shareholders.
The shareholder count was 83,453 in 2026-Jun, compared with 84,093 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 47.30% | 47.30% | 47.30% | 47.31% | 47.31% | 47.31% | 47.31% | 47.31% |
Institutional Investors | ||||||||
| FII Holding | 0.16% | 0.87% | 2.47% | 5.82% | 9.14% | 9.52% | 7.51% | 8.04% |
| DII Holding | 0.10% | 0.19% | 0.00% | 0.08% | 0.04% | 0.29% | 0.50% | 0.21% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.58% | 21.54% | 20.33% | 17.14% | 15.42% | 15.30% | 15.37% | 13.06% |
| Other Holding | 29.86% | 30.10% | 29.89% | 29.65% | 28.09% | 27.58% | 29.31% | 31.39% |
| Shareholder Count | 83,453 | 84,093 | 87,336 | 88,966 | 90,891 | 93,417 | 96,927 | 99,586 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Tarsons Products. Tarsons Products dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹2.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹2.00 | 0.66% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Tarsons Products Stock Index Membership - Nifty & Sensex
See which indices include Tarsons Products stock. Check TARSONS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 3 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.
Complete Index List
Tarsons Products Market Events Screener - Corporate Actions
Get Tarsons Products corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Tarsons Products stock events that may affect TARSONS share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 24, 2026, with a record date of September 24, 2026.
It is followed by Quarterly Result Announcement dated August 10, 2026 and Quarterly Result Announcement dated May 22, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | 6.95% |
| 2026-08-10 | 2026-08-10 | Quarterly Result Announcement | NA | -1.02% |
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | 1.28% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 5.73% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -7.25% |
| 2025-09-22 | 2025-09-22 | Annual General Meeting | NA | -17.14% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.51% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 11.62% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.49% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 3.04% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | -2.81% |
| 2024-09-20 | 2024-09-20 | Dividend | ₹ 2.00 /share | 11.87% |
Tarsons Products Competitors Screener - Peer Stocks Comparison
Screen TARSONS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 16,671 | 53.01 | 1,995 | 13.43% | 321 | 38.39 |
| Tarsons Products | 1,758 | 162.11 | 447 | 9.38% | 14 | 52.16 |
| Q-Line Biotech | 1,569 | 27.91 | 342 | 5.93% | 56 | 56.73 |
| Laxmi Dental | 1,058 | 34.32 | 286 | 18.15% | 26 | 40.45 |
| Hemant Surgical Industries | 865 | 46.91 | 238 | 112.99% | 18 | 71.99 |
| Vasa Denticity | 754 | 65.19 | 283 | 12.77% | 10 | 63.76 |
| Osel Devices | 691 | 23.44 | 295 | 57.88% | 29 | 52.29 |
| Fabtech Technologies | 656 | 13.06 | 411 | 22.29% | 36 | 50.42 |
| Prevest Denpro | 462 | 21.15 | 77 | 14.31% | 21 | 49.95 |
| QMS Medical Allied Services | 419 | 31.72 | 174 | 10.27% | 12 | 85.82 |
Tarsons Products Company Announcements - News & Reports Screener
Screen TARSONS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 5, 2026.
The next most recent announcements are dated October 5, 2026 and October 1, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-05 | Re-Appointment Of Director At The 43Rd Annual General Meeting (AGM) Of The Company. | - |
| 2026-10-05 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-01 | Closure of Trading Window | - |
| 2026-10-01 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-29 | Response On Clarification Sought On Spurt In Volume Of Tarsons Products Limited | - |
| 2026-09-29 | Clarification sought from Tarsons Products Ltd | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-02 | Intimation Under Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Letter To Shareholders | - |
| 2026-09-02 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-02 | Notice Of The 43Rd Annual General Meeting Of The Company For The Financial Year Ended March 31 2026 | - |
| 2026-09-02 | Notice Of The 43Rd Annual General Meeting Of The Company For The Financial Year Ended March 31 2026 | - |
| 2026-09-02 | Reg. 34 (1) Annual Report. | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-10 | Update Regarding The Finalization Of The Date Of 43Rd Annual General Meeting Of The Company. | - |
| 2026-08-10 | Financial Results Of The Company For The Quarter Ended June 30 2026. | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹335.95, within a 52-week range of ₹166.46 to ₹361.50. The P/E ratio is 162.11 and the P/B ratio is 2.84, with earnings per unit of ₹2.69. Market capitalisation stands at ₹1,757.67 Cr. The company operates in the Healthcare sector, in the Medical Equipment industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 5 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.